Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

Frovatriptan plus dexketoprofen in the treatment of menstrually related migraine: an open study.

Allais G, Rolando S, Schiapparelli P, Airola G, Borgogno P, Mana O, Benedetto C.

Neurol Sci. 2013 May;34 Suppl 1:S179-81. doi: 10.1007/s10072-013-1390-0.

2.

Comparison of frovatriptan plus dexketoprofen (25 mg or 37.5 mg) with frovatriptan alone in the treatment of migraine attacks with or without aura: a randomized study.

Tullo V, Valguarnera F, Barbanti P, Cortelli P, Sette G, Allais G, d'Onofrio F, Curone M, Zava D, Pezzola D, Benedetto C, Frediani F, Bussone G.

Cephalalgia. 2014 May;34(6):434-45. doi: 10.1177/0333102413515342. Epub 2013 Dec 20. Erratum in: Cephalalgia. 2015 Mar;35(3):286. Cephalalgia. 2015 Mar;35(3):286.

PMID:
24363238
3.

Early (≤ 1-h) vs. late (>1-h) administration of frovatriptan plus dexketoprofen combination vs. frovatriptan monotherapy in the acute treatment of migraine attacks with or without aura: a post hoc analysis of a double-blind, randomized, parallel group study.

Allais G, Bussone G, Tullo V, Cortelli P, Valguarnera F, Barbanti P, Sette G, Frediani F, D'Arrigo G, d'Onofrio F, Comi G, Curone M, Colombo B, Omboni S, Benedetto C.

Neurol Sci. 2015 May;36 Suppl 1:161-7. doi: 10.1007/s10072-015-2165-6. Erratum in: Neurol Sci. 2016 Feb;37(2):331.

PMID:
26017535
4.

Efficacy of frovatriptan in the acute treatment of menstrually related migraine: analysis of a double-blind, randomized, cross-over, multicenter, Italian, comparative study versus rizatriptan.

Savi L, Omboni S, Lisotto C, Zanchin G, Ferrari MD, Zava D, Pinessi L.

J Headache Pain. 2011 Dec;12(6):609-15. doi: 10.1007/s10194-011-0366-9. Epub 2011 Aug 13.

5.

Safety and tolerability of short-term preventive frovatriptan: a combined analysis.

MacGregor EA, Brandes JL, Silberstein S, Jeka S, Czapinski P, Shaw B, Pawsey S.

Headache. 2009 Oct;49(9):1298-314. doi: 10.1111/j.1526-4610.2009.01513.x.

PMID:
19788471
6.

Frovatriptan 2.5 mg plus dexketoprofen (25 mg or 37.5 mg) in menstrually related migraine. Subanalysis from a double-blind, randomized trial.

Allais G, Bussone G, Tullo V, Cortelli P, Valguarnera F, Barbanti P, Sette G, D'Onofrio F, Curone M, Benedetto C.

Cephalalgia. 2015 Jan;35(1):45-50. doi: 10.1177/0333102414542290. Epub 2014 Jul 22.

7.

The efficacy and tolerability of frovatriptan and dexketoprofen for the treatment of acute migraine attacks.

Allais G, Rolando S, De Lorenzo C, Benedetto C.

Expert Rev Neurother. 2014 Aug;14(8):867-77. doi: 10.1586/14737175.2014.940901.

PMID:
25056381
8.

Spotlight on frovatriptan: a review of its efficacy in the treatment of migraine.

Allais G, Benedetto C.

Drug Des Devel Ther. 2016 Oct 3;10:3225-3236. eCollection 2016. Review.

9.

Efficacy of frovatriptan in the acute treatment of menstrually related migraine: analysis of a double-blind, randomized, multicenter, Italian, comparative study versus zolmitriptan.

Allais G, Tullo V, Benedetto C, Zava D, Omboni S, Bussone G.

Neurol Sci. 2011 May;32 Suppl 1:S99-104. doi: 10.1007/s10072-011-0547-y.

10.

Efficacy of early vs. late use of frovatriptan combined with dexketoprofen vs. frovatriptan alone in the acute treatment of migraine attacks with or without aura.

Allais G, Tullo V, Cortelli P, Barbanti P, Valguarnera F, Sette G, D'Onofrio F, Curone M, Zava D, Pezzola D, Reggiardo G, Omboni S, Frediani F, Bussone G, Benedetto C.

Neurol Sci. 2014 May;35 Suppl 1:107-13. doi: 10.1007/s10072-014-1751-3.

11.

Scheduled short-term prevention with frovatriptan for migraine occurring exclusively in association with menstruation.

Silberstein SD, Berner T, Tobin J, Xiang Q, Campbell JC.

Headache. 2009 Oct;49(9):1283-97. doi: 10.1111/j.1526-4610.2009.01509.x. Epub 2009 Sep 14.

PMID:
19751371
12.

Rapid responders to frovatriptan in acute migraine treatment: results from a long-term, open-label study.

Spierings EL, Keywood C.

Pain Med. 2009 May-Jun;10(4):633-8. doi: 10.1111/j.1526-4637.2009.00618.x. Epub 2009 Apr 22.

PMID:
19453958
13.
14.

A randomized trial of frovatriptan for the intermittent prevention of menstrual migraine.

Silberstein SD, Elkind AH, Schreiber C, Keywood C.

Neurology. 2004 Jul 27;63(2):261-9.

PMID:
15277618
15.

Adding NSAIDs to triptans: could less be more?

Loder E, Weizenbaum E.

Cephalalgia. 2014 May;34(6):407-8. doi: 10.1177/0333102413515351. Epub 2013 Dec 11. No abstract available.

PMID:
24335849
16.

Open-label, long-term tolerability of naratriptan for short-term prevention of menstrually related migraine.

Brandes JL, Smith T, Diamond M, Ames MH.

Headache. 2007 Jun;47(6):886-94.

PMID:
17578540
17.

Almotriptan 12.5 mg in menstrually related migraine: a randomized, double-blind, placebo-controlled study.

Allais G, Bussone G, D'Andrea G, Moschiano F, d'Onofrio F, Valguarnera F, Manzoni GC, Grazzi L, Allais R, Benedetto C, Acuto G.

Cephalalgia. 2011 Jan;31(2):144-51. doi: 10.1177/0333102410378048. Epub 2010 Jul 26.

18.

Characteristics of migraine attacks and responses to almotriptan treatment: a comparison of menstrually related and nonmenstrually related migraines.

Diamond ML, Cady RK, Mao L, Biondi DM, Finlayson G, Greenberg SJ, Wright P.

Headache. 2008 Feb;48(2):248-58. doi: 10.1111/j.1526-4610.2007.01019.x.

PMID:
18234046
19.

A double-blind, randomized, multicenter, Italian study of frovatriptan versus almotriptan for the acute treatment of migraine.

Bartolini M, Giamberardino MA, Lisotto C, Martelletti P, Moscato D, Panascia B, Savi L, Pini LA, Sances G, Santoro P, Zanchin G, Omboni S, Ferrari MD, Brighina F, Fierro B.

J Headache Pain. 2011 Jun;12(3):361-8. doi: 10.1007/s10194-011-0325-5. Epub 2011 Mar 25.

20.

Rizatriptan efficacy in ICHD-II pure menstrual migraine and menstrually related migraine.

Nett R, Mannix LK, Mueller L, Rodgers A, Hustad CM, Skobieranda F, Ramsey KE.

Headache. 2008 Sep;48(8):1194-201. doi: 10.1111/j.1526-4610.2008.01093.x. Epub 2008 Apr 14.

PMID:
18422606

Supplemental Content

Support Center